| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/08/2003 | US6589960 Preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the absence of |
| 07/08/2003 | US6589959 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt |
| 07/08/2003 | US6589957 Compounds and methods of use for treatment of neurogenic inflammation |
| 07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
| 07/08/2003 | US6589955 Pediatric formulation of gatifloxacin |
| 07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
| 07/08/2003 | US6589953 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 07/08/2003 | US6589952 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders |
| 07/08/2003 | US6589951 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/08/2003 | US6589950 Treatment of inflammatory or obstructive airways disease for respiratory system disorders |
| 07/08/2003 | US6589949 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases |
| 07/08/2003 | US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 07/08/2003 | US6589947 Treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist alone or together with a glucocorticoid receptor antagonist. |
| 07/08/2003 | US6589946 Bile salt conjugates |
| 07/08/2003 | US6589945 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 07/08/2003 | US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for |
| 07/08/2003 | US6589943 Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption |
| 07/08/2003 | US6589941 Preventing or reducing formation of resistance in cytostatic treatment comprising combining BVDU, a salt thereof or BVDU in protected form or in prodrug form with at least one cytostatic agent in order to prevent or reduce the formation |
| 07/08/2003 | US6589939 Camptothecin derivatives having antitumor activity |
| 07/08/2003 | US6589934 Methods of treatment of non insulin dependent diabetes mellitus, antagonists of the delayed rectifier potassium channel Kv2.1, methods of using and preparing the antagonists and assays for identifying such antagonist |
| 07/08/2003 | US6589767 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 07/08/2003 | US6589588 For lowering the absorption of cholesterol from the digestive tract; sterol and/or stanol fatty acid ester composition, wherein the fatty acid moiety comprises blend of less 7% saturated fatty acids and more than 50% polyunsaturated |
| 07/08/2003 | US6589576 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas) |
| 07/08/2003 | US6589573 A crude extract obtained by extracting Lagerstroemia speciosa belonging to the genus Lagerstroemia( banana plant) with water, hot water, an organic solvent or a mixed solution, used as xanthine oxidase inhibitor |
| 07/08/2003 | US6589567 Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition |
| 07/08/2003 | US6589566 Composition comprising theanine |
| 07/08/2003 | US6589564 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate |
| 07/08/2003 | US6589560 Stable glassy state powder formulations |
| 07/08/2003 | US6589557 Porous celecoxib matrices and methods of manufacture thereof |
| 07/08/2003 | US6589555 Effervescence |
| 07/08/2003 | US6589553 Controlled release oral dosage form |
| 07/08/2003 | US6589552 Microstructure grains; fine particle size |
| 07/08/2003 | US6589548 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 07/08/2003 | US6589547 Sustained-release preparation for AII antagonist, production and use thereof |
| 07/08/2003 | US6589546 Polymeric coatings for controlled delivery of active agents |
| 07/08/2003 | US6589542 Topical composition comprising a functionally alkylating cosmetic bonding agent |
| 07/08/2003 | US6589540 Cosmetic composition for skin care containing retinol and epidermal growth factor |
| 07/08/2003 | US6589536 Soft gelatin capsule manufacture |
| 07/08/2003 | US6589535 Nutritional supplement based on blackcurrent seed oil |
| 07/08/2003 | US6589523 Agent for gene therapy of dilated cardiomyopathy |
| 07/08/2003 | US6589520 Treatment of psoriasis, allergies and auto-immune disorders of the skin with cis-6-hexadecenoic acid |
| 07/08/2003 | US6589504 Binding or aggregating fibrils with radiolabeled quinoline-hydrazone compound |
| 07/08/2003 | US6589223 Method and compositions for use in perfusion applications |
| 07/08/2003 | CA2361954C Metered dose inhaler for albuterol |
| 07/08/2003 | CA2347975C Reduction of hair growth |
| 07/08/2003 | CA2290501C Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 07/08/2003 | CA2286511C Novel macrolide derivatives |
| 07/08/2003 | CA2285208C Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 07/08/2003 | CA2280395C New hydroxamic acid derivatives, their preparation process and the pharmaceutical compositions which contain them |
| 07/08/2003 | CA2278845C Process for preparing quinolone and naphthyridone carboxylic acids |
| 07/08/2003 | CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 07/08/2003 | CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 07/08/2003 | CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them |
| 07/08/2003 | CA2254682C Method of treating eye infections with azithromycin |
| 07/08/2003 | CA2234426C Antibacterial composition for oral administration |
| 07/08/2003 | CA2233222C Skin treatment with salicylic acid esters and retinoids |
| 07/08/2003 | CA2226784C Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 07/08/2003 | CA2220281C A phospholipidic composition, method for the production of such a composition and its use |
| 07/08/2003 | CA2213608C Pharmaceutical composition stabilized with a basic agent |
| 07/08/2003 | CA2182715C Cationic biopolymers |
| 07/08/2003 | CA2153549C New benzothiadiazine derivative, process for preparing the same and pharmaceutical compositions containing said derivative |
| 07/08/2003 | CA2151096C New 1,4-oxazine tetracyclic derivatives; process for preparing them and pharmaceutical copossitions containing them |
| 07/08/2003 | CA2140428C Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 07/08/2003 | CA2131553C Use of alkylureas and hydroxyurea as contraceptive agents |
| 07/08/2003 | CA2090220C Treatment of non-inflammatory and non-infectious bowel disorders |
| 07/08/2003 | CA2059307C Bathing preparation |
| 07/08/2003 | CA1341434C Compositions and methods for administering therapeutically active compounds |
| 07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/03/2003 | WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | WO2003054226A2 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 07/03/2003 | WO2003054208A2 Method of modulating release of saccharides and uses thereof |
| 07/03/2003 | WO2003054195A1 Novel gene useful in diagnosing cancer and use thereof |
| 07/03/2003 | WO2003054161A2 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS |
| 07/03/2003 | WO2003054145A2 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054000A1 Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 07/03/2003 | WO2003053999A2 Selective arylguanidine peptides as urokinase inhibitors |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053994A1 Tetrahydrobenzfluorene derivatives |
| 07/03/2003 | WO2003053991A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 07/03/2003 | WO2003053984A1 A process for preparing n-acylated lysophosphatidylcholine and a pharmaceutical composition for treatment of metabolic bone disease comprising said compounds |
| 07/03/2003 | WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | WO2003053978A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053976A1 PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR |
| 07/03/2003 | WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | WO2003053972A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053970A1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053968A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 07/03/2003 | WO2003053967A1 Aroyl pyridinones |
| 07/03/2003 | WO2003053966A2 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 07/03/2003 | WO2003053961A1 Benzothiazoles |
| 07/03/2003 | WO2003053957A1 Benzhydryl derivatives |
| 07/03/2003 | WO2003053956A1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |